Recruiting Heart Attack Studies in Albuquerque
Ketamine for Methamphetamine Use Disorder
This study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week rando...
A Study of K-645 in the Treatment of Multiple Migraine Attacks
This is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the treatment of patient...
About Heart Attack Clinical Trials in Albuquerque
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Albuquerque, NM. These studies are seeking a combined 240 participants. Research is being sponsored by University of Texas Southwestern Medical Center, Kallyope Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Albuquerque — FAQ
Are there heart attack clinical trials in Albuquerque?
Yes, there are 2 heart attack clinical trials currently recruiting in Albuquerque, NM. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Albuquerque?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Albuquerque research site will contact you about next steps.
Are clinical trials in Albuquerque free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Albuquerque studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Albuquerque are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov